Skip to main content
Oxford University Hospitals NHS Foundation Trust
Cancer Services

Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice.

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Gynaecological Oncology MDT

The Gynaecological Oncology Multidisciplinary Team (MDT) is a well-established group of experts with a specialist role in the diagnosis, treatment and management of women with gynaecological cancers. The team comprises doctors, nurses and other healthcare professionals who manage the treatment of gynaecological cancers in Oxfordshire and is the tertiary referral centre for the Thames Valley Cancer Network.

The team meets every Monday to discuss, in confidence, newly referred patients with a suspected or confirmed diagnosis of a gynaecological cancer. The MDT meetings offer a forum for the team members to plan and agree a recommended programme of treatment specific to individual patient needs.

This approach ensures that all necessary investigations are carried out as quickly as possible and the best available treatment is offered. Treatment options are then discussed with the patient and her family at a subsequent appointment, which is often later that week.

The Gynaecological Oncology MDT links with all those engaged in gynaecological cancer care within the Thames Valley Cancer Network via video-linked joint MDT meetings with colleagues in Aylesbury, High Wycombe, Reading and Swindon and liaises with community and primary care teams.

The Gynaecological Oncology MDT currently includes the following core members.

Gynaeonocology Surgery

Professor Ahmed Ashour Ahmed

Professor Ahmed Ashour Ahmed




Professor Ahmed is a Professor of Gynaecological Oncology at the Nuffield Department of Obstetrics and Gynaecology at the University of Oxford, a Consultant Gynaecological Oncology Surgeon at the Oxford Cancer and Haematology Centre and a Fellow of St Hugh's College, Oxford.

Professor Ahmed graduated from Ain Shams University in Cairo, Egypt, and completed his PhD and Gynaecological Oncology Surgical training at the University of Cambridge, receiving postdoctoral training at M D Anderson Cancer Center in Houston, Texas, USA.

He won several prestigious national and international awards such as the MRC Clinical Research Training Fellowship, Cancer Research UK Clinician Scientist Award and, most recently, the MRC Senior Clinical Research Fellowship at the Weatherall Institute of Molecular Medicine (WIMM).

Professor Ahmed's special clinical interest is in the management of ovarian cancer.

Since moving to Oxford in 2010, he has established a clinical and translational research programme in gynaecological cancers. He is also the director of the Ovarian Cancer Cell Research Laboratory at the WIMM.

He became Chair of Gynaecological Oncology in Oxford in 2012.

Moiad Alazzam

Mr Moiad Alazzam

Consultant Gynaecological Surgeon and Oncologist

Mr Moiad Alazzam is a recognised expert in complex gynaecological surgery both open and minimally-invasive, including laparoscopy, robotics and hysteroscopic surgery.

Moiad is an experienced ultraradical surgeon for advanced and recurrent ovarian cancer with complete cytoreduction rate over 80 percent. Moiad has a special interest in microsurgery and fertility-preserving surgical techniques. Since moving to Oxford he has joined the regional service for Abnormal Invasive Placenta (AIP).

Moiad is actively involved in research. He is widely published and frequently invited to speak at national and international meetings. His main area of interest is health innovation and technology. He is a member of several national and international societies, a previous council member of British Society of Gynaecological Endoscopy (BSGE) and has chaired the guidelines and robotics subcommittees.

Mr Roberto Tozzi

Mr Roberto Tozzi




Roberto Tozzi is a consultant at Oxford University Hospitals, a Senior Lecturer at the Nuffield Department of Obstetrics and Gynaecology, University of Oxford, and a Research Member of Wolfson College.

A graduate of the Federico II University of Naples, Italy, he moved to the University of Padua for the residency in Obstetrics and Gynaecology and later on to the Friedrich Schiller University in Jena, Germany.

In Jena he started the first RCOG accredited Gynaecologic Oncology Subspecialty Training Programme in continental Europe. Following two years as subspecialty fellow in Gynaecologic Oncology in Jena, he moved to London to complete another two years in the subspecialty programme jointly held by the St Bartholomew's and Royal Marsden Hospitals.

Since moving to Oxford in 2009 he has developed the extensive surgical management of patients with ovarian cancer as well as the minimally-invasive treatment of patients with cervical and endometrial cancer.

He is currently the RCOG SST programme Director in Oxford and also the Chairman of the SIG Oncology for the European Society of Gynaecologic Endoscopy.

Mr Hooman Soleymani Majd

Mr Hooman Soleymani Majd

Mr Hooman Soleymani Majd started his Obstetrics and Gynaecology career in London, before moving to Oxford where he completed his structured postgraduate training programme. During the course of training he obtained his Member of the Royal College of Obstetricians and Gynaecologists (MRCOG), which culminated in a Certificate of Completion of Training (CCT) in Obstetrics and Gynaecology. Mr. Soleymani Majd completed a further three years of Sub-Specialty Training in Gynaecological Oncology at the Churchill Cancer Centre in Oxford and is also a BSCCP accredited Colposcopist, as well as a member of the British Gynaecological Cancer Society (BGCS).

He is an accomplished and experienced advanced laparoscopic surgeon, performing complex radical laparoscopic surgeries for uterine and cervical cancer. He has a special interest in performing ultra-radical surgery for ovarian cancer; his skill set includes upper abdominal surgery, liver mobilisation and diaphragmatic reconstruction. Mr Soleymani Majd also has a particular surgical interest in treating patients with Abnormally Invasive Placentas (AIP).

Mr Soleymani Majd has active involvement in teaching registrars/fellows and medical students from Oxford University. He is part of an Oxford research group that has a special interest in new developments in surgical techniques in ultra-radical surgery for advanced ovarian cancer, he has published many papers and been invited to speak at a number of international congresses.

Mr Soleymani Majd currently works as a Consultant in Gynaecological Oncology at the Churchill Hospital, Oxford.

To view some of the surgical procedures that Mr Soleymani Majd and the team have undertaken, please visit:

Mr Pubudu Pathiraja

Mr Pubudu Pathiraja

Mr Pubudu Pathiraja began his surgical career in Sri Lanka, before moving to the UK where he completed his structured postgraduate training programme in Obstetrics and Gynaecology.

Mr Pathiraja is a Member of the Royal College of Obstetricians and Gynaecologists (MRCOG), and gained the Certificate of Completion of Training (CCT - 2010) in Obstetrics and Gynaecology. He then completed the Royal College of Gynaecologists certified Sub-Specialty Training in Gynaecological Oncology at Oxford University Hospitals. He is a member of the British Gynaecological Cancer Society (BGCS) and the BMA, and is a BSCCP-accredited Colposcopist and trainer.

Mr Pathiraja treats all types of gynaecological cancers and is an accomplished and experienced advanced laparoscopic surgeon, performing laparoscopic surgeries / minimal access surgery (MAS) for uterine, cervical and highly selected early stage ovarian cancer.

He has a special interest in performing ultra-radical surgery for ovarian cancer; palliative surgery for recurrent disease and exenterative procedures.

Mr Pathiraja also has a particular surgical interest in treating pre-cancerous disease of the vulva and cervix and also exploring the value of prophylactic surgery for ovarian disease.

Mr Pathiraja has active involvement in teaching registrars/fellows and medical students from the University of Oxford. He is a firm believer in working together with relevant specialties to achieve safest and best quality care for patients. His vision is to disseminate high quality and safe Gynaecological Oncology care for all women in developing and resource poor countries by volunteering and training their specialists.

Clinical Oncology

  • Dr Amanda Horne
  • Dr Sally Trent

Medical Oncology

Dr Shibani Nicum

Dr Shibani Nicum is a Consultant Medical Oncologist specialising in the treatment of patients with ovarian and other gynaecological cancers at the Oxford Cancer Centre.

She graduated from the University of Birmingham and completed her specialist Medical Oncology training at the Royal Marsden Hospital in London, prior to taking up her current post at the Cancer Centre in Oxford in 2009.

Dr Nicum is the Lead Clinician for the Gynaeoncology Unit and the Oxford Multidisciplinary Team. She is also the Lead for the Thames Valley Gynaecology Cancer Alliance Group. Through these roles, she is committed to ensuring that all patients have streamlined access to high quality, evidence-based treatment. Her particular interests are in BRCA mutated cancers, and the development of new therapies in order to personalise patient care.

Dr Nicum won a national peer-reviewed grant from Cancer Research UK to undertake laboratory-based research and was awarded a DPhil from the University of Oxford in 2007. She has also co-authored many peer-reviewed journal articles and book chapters in the field of medical oncology.

Dr Nicum is the Oxford Gynaeoncology Research Lead and is actively involved in translating advances in the laboratory into benefit for patients. She is the Chief Investigator for the CRUK OCTOVA Trial, the 6MP BRCA trial and the upcoming ICON9 Trial. She is also the Principal Investigator for a number of clinical trials of novel agents for women with advanced malignancies. Dr Nicum is also an active committee member of the UK National Cancer Research Institute Gynaecological Oncology Clinical Studies Group and also the Ovarian Cancer Clinical Studies Subgroup.

Dr Rene Roux


  • Dr Stephen Damato
  • Dr Sunanda Dhar
  • Dr Sanjiv Manek
  • Dr Mark McCole


  • Dr Zoe Traill
  • Dr Catherine Johnson

Senior Specialist Nurses

  • Lucy Griffiths
    Senior Gynaeoncology Senior Specialist Nurse
  • Simeone Wood
    Gynaeoncology Senior Specialist Nurse

MDT coordinator

Tel: 01865 235362


Tel: 01865 235662 / 235362

Further information

Fertility preservation

We now offer a service which preserves fertility in patients undergoing chemotherapy or radiotherapy. This involves the freezing of ovarian or testicular tissue for reimplantation later in life.

For more information please visit: Fertility preservation: tissue cryopreservation

Find us and contact us

Gynaecological Oncology Offices
East Entrance
Churchill Hospital
Old Road
Oxford OX3 7LJ

Tel: 0300 304 7777